514 related articles for article (PubMed ID: 34029971)
1. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
[TBL] [Abstract][Full Text] [Related]
2. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
[TBL] [Abstract][Full Text] [Related]
3. Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation.
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Rudakova EV; Stupina TS; Terentiev AA; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Bioorg Chem; 2020 Jan; 94():103387. PubMed ID: 31735356
[TBL] [Abstract][Full Text] [Related]
4. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
5. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and
Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Astakhova TY; Rudakova EV; Proshin AN; Serkov IV; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
Molecules; 2020 Aug; 25(17):. PubMed ID: 32867324
[TBL] [Abstract][Full Text] [Related]
6. Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Grishchenko MV; Lushchekina SV; Astakhova TY; Serebryakova OG; Timokhina EN; Zhilina EF; Shchegolkov EV; Ulitko MV; Radchenko EV; Palyulin VA; Burgart YV; Saloutin VI; Bachurin SO; Richardson RJ
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768608
[TBL] [Abstract][Full Text] [Related]
7. Piperazine-2-carboxylic acid derivatives as MTDLs anti-Alzheimer agents: Anticholinesterase activity, mechanistic aspect, and molecular modeling studies.
Soliman AM; Abd El-Wahab HAA; Akincioglu H; Gülçin İ; Omar FA
Bioorg Chem; 2024 Jan; 142():106916. PubMed ID: 37913584
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, bioactivity and molecular modeling studies on potential anti-Alzheimer piperidinehydrazide-hydrazones.
Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alptuzun V; Erciyas E; Holzgrabe U
Bioorg Chem; 2019 Jun; 87():888-900. PubMed ID: 30538051
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological evaluation of novel xanthone-alkylbenzylamine hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Zhang Z; Guo J; Cheng M; Zhou W; Wan Y; Wang R; Fang Y; Jin Y; Liu J; Xie SS
Eur J Med Chem; 2021 Mar; 213():113154. PubMed ID: 33476932
[TBL] [Abstract][Full Text] [Related]
10. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, evaluation and molecular modeling study of 4-N-phenylaminoquinolines for Alzheimer disease treatment.
Zhu J; Wang LN; Cai R; Geng SQ; Dong YF; Liu YM
Bioorg Med Chem Lett; 2019 Jun; 29(11):1325-1329. PubMed ID: 30956012
[TBL] [Abstract][Full Text] [Related]
12. Conjugates of amiridine and thiouracil derivatives as effective inhibitors of butyrylcholinesterase with the potential to block β-amyloid aggregation.
Khudina OG; Grishchenko MV; Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Shchegolkov EV; Borisevich SS; Burgart YV; Saloutin VI; Charushin VN
Arch Pharm (Weinheim); 2024 Feb; 357(2):e2300447. PubMed ID: 38072670
[TBL] [Abstract][Full Text] [Related]
13. New Multifunctional Agents for Potential Alzheimer's Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones.
Elkina NA; Grishchenko MV; Shchegolkov EV; Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Astakhova TY; Radchenko EV; Palyulin VA; Zhilina EF; Perminova AN; Lapshin LS; Burgart YV; Saloutin VI; Richardson RJ
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358901
[TBL] [Abstract][Full Text] [Related]
14. New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer's Disease Treatment.
Makhaeva GF; Kovaleva NV; Rudakova EV; Boltneva NP; Lushchekina SV; Faingold II; Poletaeva DA; Soldatova YV; Kotelnikova RA; Serkov IV; Ustinov AK; Proshin AN; Radchenko EV; Palyulin VA; Richardson RJ
Molecules; 2020 Dec; 25(24):. PubMed ID: 33322783
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
16. Conjugates of Tacrine with Salicylamide as Promising Multitarget Agents for Alzheimer's Disease.
Grishchenko MV; Makhaeva GF; Burgart YV; Rudakova EV; Boltneva NP; Kovaleva NV; Serebryakova OG; Lushchekina SV; Astakhova TY; Zhilina EF; Shchegolkov EV; Richardson RJ; Saloutin VI
ChemMedChem; 2022 May; 17(10):e202200080. PubMed ID: 35322571
[TBL] [Abstract][Full Text] [Related]
17. Rational design, synthesis and biological screening of triazine-triazolopyrimidine hybrids as multitarget anti-Alzheimer agents.
Jameel E; Meena P; Maqbool M; Kumar J; Ahmed W; Mumtazuddin S; Tiwari M; Hoda N; Jayaram B
Eur J Med Chem; 2017 Aug; 136():36-51. PubMed ID: 28478343
[TBL] [Abstract][Full Text] [Related]
18. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
Gao H; Jiang Y; Zhan J; Sun Y
Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Biological Activity of Some Benzochromenoquinolinones: Tacrine Analogs as Potent Anti-Alzheimer's Agents.
Mahdavi M; Hariri R; Mirfazli SS; Lotfian H; Rastergari A; Firuzi O; Edraki N; Larijani B; Akbarzadeh T; Saeedi M
Chem Biodivers; 2019 Apr; 16(4):e1800488. PubMed ID: 30720917
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, pharmacological assessment, molecular modeling and in silico studies of fused tricyclic coumarin derivatives as a new family of multifunctional anti-Alzheimer agents.
Shaik JB; Palaka BK; Penumala M; Kotapati KV; Devineni SR; Eadlapalli S; Darla MM; Ampasala DR; Vadde R; Amooru GD
Eur J Med Chem; 2016 Jan; 107():219-32. PubMed ID: 26588065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
